Evidence map›Paper›PMID 35067989›Full record

ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2022

Duration of acceptable delay between the time of diagnosis and treatment of melanoma, cutaneous squamous cell carcinoma and basal cell carcinoma.

M Alam, J R Etzkorn, J G Albertini, J S Bordeaux, M L Council, I A Maher, K S Nehal, D G Brodland, A F Haas, B Y Kang and 4 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the European Academy of Dermatology and Venereology : JEADV, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

M AlamDepartment of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.ORCID 0000-0001-8752-3821
J R EtzkornDepartment of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
J G AlbertiniThe Skin Surgery Center, Winston-Salem, NC, USA.
J S BordeauxDepartment of Dermatology, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
M L CouncilDivision of Dermatology, Center for Dermatologic and Cosmetic Surgery, Washington University in Saint Louis, Saint Louis, MO, USA.
I A MaherDepartment of Dermatology, University of Minnesota, Minneapolis, MN, USA.
K S NehalDermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
D G BrodlandZitelli & Brodland, P.C. Skin Cancer Center, Pittsburgh, PA, USA.
A F HaasSutter Health/Department of Dermatology, University of California-Davis, Sacramento, CA, USA.
B Y KangDepartment of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
S A IbrahimDepartment of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
R E ChristensenDepartment of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
E PoonDepartment of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
B WorleyDepartment of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Basal Cell CarcinomaCarcinoma, Squamous CellMelanomaNeoplasms, Basal CellSkin NeoplasmsHumans

Identifiers

PMID35067989
PMCPMC10314821

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.